← Back to headlines
Novo Nordisk's Primary Owner to Establish Obesity Drug Incubators Across Europe
The primary owner of Novo Nordisk A/S (NVO) plans to open several incubators across Europe dedicated to the development of obesity drugs.
23 Jun, 19:53 — 23 Jun, 19:53
Sources
Showing 1 of 1 sources
